Literature DB >> 6192342

Detection of a novel human class II HLA antigen.

A J Watson, R DeMars, I S Trowbridge, F H Bach.   

Abstract

Genetic, molecular and cellular analyses of the HLA-D region of the major histocompatability complex (MHC) in man have led to the definition of three different products. Two of these, DR and MB (the latter also known as DC (ref. 1) and LB-E (ref. 2)) are defined with serological reagents; the third, known as SB (ref. 3) and PL-3 (ref. 4) is defined with primed lymphocyte typing (PLT) cells. The classical features attributed to HLA-D region encoded (class II) molecules are that they are cell-surface dimers consisting of a structurally conserved alpha-chain noncovalently associated with a polymorphic beta-chain and that they are found primarily on B lymphocytes, some monocyte populations, endothelial and certain other cells. Using these criteria a monoclonal antibody, B7/21, was described as reactive with HLA-DR (ref. 7). We have now re-evaluated B7/21 antibody reactivity using mutant lymphoblastoid cell lines. It appears that this antibody does not react with the molecularly defined D region products described to date but instead, recognizes a class II antigen with distinctive molecular characteristics. We provisionally refer to this antigen as FA.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192342     DOI: 10.1038/304358a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  98 in total

1.  A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytes.

Authors:  N Fernandez; M Kurpisz; M Labeta; J Sachs; G Pawelec
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

2.  Luteinization of human granulosa cells in vivo is associated with expression of MHC class II antigens.

Authors:  E L Khoury; L A Marshall
Journal:  Cell Tissue Res       Date:  1990-11       Impact factor: 5.249

3.  T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis.

Authors:  W L Chang; R G Audet; B D Aizenstein; L H Hogan; R I DeMars; B S Klein
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Highly polymorphic products of both HLA-DR and HLA-DQ genes contribute to the polymorphism of the HLA-DRw13 haplotype.

Authors:  J Michon; Y Henin; G Sterkers; C Freidel; L Gebuhrer; H Betuel; J Y Muller; J P Levy
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

5.  Gold-specific T cells in rheumatoid arthritis patients treated with gold.

Authors:  P Romagnoli; G A Spinas; F Sinigaglia
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

6.  Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.

Authors:  M T Walters; F K Stevenson; R Goswami; J L Smith; M I Cawley
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

7.  L cells expressing DQ molecules of the DR3 and DR4 haplotypes: reactivity patterns with mAbs.

Authors:  D S Monos; E Czanky; S J Ono; S F Radka; D Kappes; J L Strominger
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens.

Authors:  M Heike; O Röhrig; H E Gabbert; R Moll; K H Meyer zum Büschenfelde; W G Dippold; A Knuth
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

10.  Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.

Authors:  M Maio; B Gulwani; S Tombesi; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.